(UEQU) UBS CMCI Ex-Agriculture SF - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BZ2GV965

Commodities, Metals, Energy

Description: UEQU UBS CMCI Ex-Agriculture SF

Additional Sources for UEQU ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

UEQU ETF Overview

Market Cap in USD 61m
Category Commodities - Broad Basket
TER 0.30%
IPO / Inception 2016-03-24

UEQU ETF Ratings

Growth Rating 51.2
Fundamental -
Dividend Rating 0.0
Rel. Strength -6.51
Analysts -
Fair Price Momentum 180.46 EUR
Fair Price DCF -

UEQU Dividends

Currently no dividends paid

UEQU Growth Ratios

Growth Correlation 3m 60.8%
Growth Correlation 12m 15%
Growth Correlation 5y 65.9%
CAGR 5y 12.67%
CAGR/Max DD 5y 0.56
Sharpe Ratio 12m -0.27
Alpha -13.28
Beta 0.331
Volatility 16.42%
Current Volume 0.1k
Average Volume 20d 0.1k
What is the price of UEQU shares?
As of July 06, 2025, the stock is trading at EUR 187.14 with a total of 138 shares traded.
Over the past week, the price has changed by +0.40%, over one month by +0.03%, over three months by +0.59% and over the past year by -6.71%.
Is UBS CMCI Ex-Agriculture SF a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, UBS CMCI Ex-Agriculture SF (XETRA:UEQU) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.20 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UEQU is around 180.46 EUR . This means that UEQU is currently overvalued and has a potential downside of -3.57%.
Is UEQU a buy, sell or hold?
UBS CMCI Ex-Agriculture SF has no consensus analysts rating.
What are the forecasts for UEQU share price target?
According to our own proprietary Forecast Model, UEQU UBS CMCI Ex-Agriculture SF will be worth about 199.4 in July 2026. The stock is currently trading at 187.14. This means that the stock has a potential upside of +6.56%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 199.4 6.6%